136 related articles for article (PubMed ID: 2173996)
1. Elevated prostaglandin E2 levels in bronchoalveolar lavage fluid of patients with bronchogenic carcinoma.
LeFever A; Funahashi A
Chest; 1990 Dec; 98(6):1397-402. PubMed ID: 2173996
[TBL] [Abstract][Full Text] [Related]
2. Association of increased prostaglandin E2 content in bronchoalveolar lavage fluid and intrathoracic malignancy.
Funahashi A; Harland RW; LeFever A
Chest; 1994 Jul; 106(1):166-72. PubMed ID: 8020267
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulation by bronchial lavage cells in normal individuals and patients with bronchogenic carcinoma.
Weissman DN; deShazo RD; Banks DE; Baser Y
Am J Med Sci; 1986 Oct; 292(4):187-92. PubMed ID: 3019138
[TBL] [Abstract][Full Text] [Related]
4. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte subsets in bronchoalveolar lavage fluid and in circulating blood in epidermoid bronchogenic carcinoma.
Piazza G; Marchi E; Scaglione F; Montoli CC; Losi S; Scarpazza G
Respiration; 1990; 57(1):28-36. PubMed ID: 2359893
[TBL] [Abstract][Full Text] [Related]
6. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue.
Bridgeman MM; Marsden M; Selby C; Morrison D; MacNee W
Thorax; 1994 Jul; 49(7):670-5. PubMed ID: 8066561
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of hyaluronic acid values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma.
Hernández Hernández JR; García García JM; Martínez Muñíz MA; Allende Monclus MT; Ruibal Morell A
Int J Biol Markers; 1995; 10(3):149-55. PubMed ID: 8551057
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation and histologic classification of bronchogenic carcinoma.
Hainau B; Dombernowsky P; Hansen HH; Borgeskov S
J Natl Cancer Inst; 1977 Oct; 59(4):1113-8. PubMed ID: 198555
[TBL] [Abstract][Full Text] [Related]
9. Lymphokine-activated killer cell activity in lung cancer.
LeFever A; Funahashi A
Chest; 1991 Feb; 99(2):292-7. PubMed ID: 1989785
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC).
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():123-35. PubMed ID: 9337531
[TBL] [Abstract][Full Text] [Related]
11. HLA antigens and bronchogenic carcinoma in the Greek population.
Toumbis M; Zervas J; Anagnostopoulou O; Konstantopoulos K; Krimbeni G; Kotsovoulou V; Fessas F
Acta Oncol; 1991; 30(5):575-8. PubMed ID: 1654063
[TBL] [Abstract][Full Text] [Related]
12. Soluble Human Leukocyte Antigen-G in the Bronchoalveolar Lavage of Lung Cancer Patients.
Montilla D; Pérez M; Borges L; Bianchi G; Cova JA
Arch Bronconeumol; 2016 Aug; 52(8):420-4. PubMed ID: 27004472
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
Mao JT; Roth MD; Serio KJ; Baratelli F; Zhu L; Holmes EC; Strieter RM; Dubinett SM
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5835-41. PubMed ID: 14676104
[TBL] [Abstract][Full Text] [Related]
14. Lung natural killer and interleukin-2 activity in lung cancer. A pulmonary compartment of augmented natural killer activity occurs in patients with bronchogenic carcinoma.
Pitchenik AE; Guffee J; Stein-Streilein J
Am Rev Respir Dis; 1987 Dec; 136(6):1327-32. PubMed ID: 3500659
[TBL] [Abstract][Full Text] [Related]
15. Cytokines in patients with lung cancer.
Matanić D; Beg-Zec Z; Stojanović D; Matakorić N; Flego V; Milevoj-Ribić F
Scand J Immunol; 2003 Feb; 57(2):173-8. PubMed ID: 12588664
[TBL] [Abstract][Full Text] [Related]
16. Tumor associated antigen with pulmonary neoplasms.
Lo Gerfo P; Herter FP; Braun J; Hansen HJ
Ann Surg; 1972 Apr; 175(4):495-500. PubMed ID: 4336486
[No Abstract] [Full Text] [Related]
17. [Change of prostaglandin E2 and interleukin-12, interleukin-13 in the bronchoalveolar lavage fluid and the serum of the patients with idiopathic pulmonary fibrosis].
Li JZ; Li ZH; Kang J; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):378-80. PubMed ID: 15256084
[TBL] [Abstract][Full Text] [Related]
18. Aspergillus colonization in patients with bronchogenic carcinoma.
Ali S; Malik A; Bhargava R; Shahid M; Fatima N
Asian Cardiovasc Thorac Ann; 2014 May; 22(4):460-4. PubMed ID: 24771735
[TBL] [Abstract][Full Text] [Related]
19. Bronchogenic carcinoma. A study of 109 cases.
Jain NK; Madan A; Sharma TN; Agnihotri SP; Saxena A; Mandhana RG
J Assoc Physicians India; 1989 Jun; 37(6):379-82. PubMed ID: 2556362
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous lymphokine activated killer (LAK) activity in bronchoalveolar lavage cells from patients with bronchogenic carcinoma.
Stein-Streilein J; Guffee J; Ramos M; Pitchenik AE
Reg Immunol; 1989; 2(6):370-5. PubMed ID: 2485685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
